Literature DB >> 12814980

Risk factors for venous thromboembolism.

Frederick A Anderson1, Frederick A Spencer.   

Abstract

Until the 1990s, venous thromboembolism (VTE) was viewed primarily as a complication of hospitalization for major surgery (or associated with the late stage of terminal illness). However, recent trials in patients hospitalized with a wide variety of acute medical illnesses have demonstrated a risk of VTE in medical patients comparable with that seen after major general surgery. In addition, epidemiologic studies have shown that between one quarter and one half of all clinically recognized symptomatic VTEs occur in individuals who are neither hospitalized nor recovering from a major illness. This expanding understanding of the population at risk challenges physicians to carefully examine risk factors for VTE to identify high-risk patients who could benefit from prophylaxis. Factors sufficient by themselves to prompt physicians to consider VTE prophylaxis include major surgery, multiple trauma, hip fracture, or lower extremity paralysis because of spinal cord injury. Additional risk factors, such as previous VTE, increasing age, cardiac or respiratory failure, prolonged immobility, presence of central venous lines, estrogens, and a wide variety of inherited and acquired hematological conditions contribute to an increased risk for VTE. These predisposing factors are seldom sufficient by themselves to justify the use of prophylaxis. Nevertheless, individual risk factors, or combinations thereof, can have important implications for the type and duration of appropriate prophylaxis and should be carefully reviewed to assess the overall risk of VTE in each patient.

Entities:  

Mesh:

Year:  2003        PMID: 12814980     DOI: 10.1161/01.CIR.0000078469.07362.E6

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  355 in total

1.  Prolonged use of thromboprophylaxis may not be necessary in laparoscopic colorectal surgery.

Authors:  Paulus Menno Verheijen; Andrew R L Stevenson; Russel W Stitz; David A Clark; Andrew J Clark; John W Lumley
Journal:  Int J Colorectal Dis       Date:  2011-01-27       Impact factor: 2.571

2.  New anticoagulants emerge, how can we use them for acute pulmonary embolism?

Authors:  Jens Eckardt; Mads Nybo
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

3.  Office-based anesthesia.

Authors:  Joseph P Hunstad; Philip H Walk
Journal:  Semin Plast Surg       Date:  2007-05       Impact factor: 2.314

4.  Venous thrombosis at altitude presents with distinct biochemical profiles: a comparative study from the Himalayas to the plains.

Authors:  Amit Prabhakar; Tathagata Chatterjee; Nitin Bajaj; Tarun Tyagi; Anita Sahu; Neha Gupta; Babita Kumari; Velu Nair; Bhuvnesh Kumar; Mohammad Zahid Ashraf
Journal:  Blood Adv       Date:  2019-11-26

Review 5.  Evidence behind quality of care measures for venous thromboembolism and atrial fibrillation.

Authors:  G Eymin; A K Jaffer
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 6.  Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing.

Authors:  Charles E Mahan; Mario Pini; Alex C Spyropoulos
Journal:  Intern Emerg Med       Date:  2010-02-23       Impact factor: 3.397

7.  Adherence to thromboprophylaxis guidelines in elderly patients with hospital acquired venous thromboembolism: a case control study.

Authors:  Jason Suh; Amishi Desai; Anish Desai; Josephine Dela Cruz; Anusiyanthan Mariampillai; Alexander Hindenburg
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

8.  Right ventricular mobile thrombus in end-stage hypertrophic cardiomyopathy.

Authors:  Takahiro Kusume; Shoichi Kubokawa; Noriyoshi Kaname; Yoko Nakaoka; Toshiaki Kotani; Ryuichiro Imai; Koji Nishida; Shuichi Seki; Kazuya Kawai; Naohisa Hamashige; Yoshinori Doi
Journal:  J Cardiol Cases       Date:  2017-03-07

9.  Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

Authors:  Scott E Kasner; Balakumar Swaminathan; Pablo Lavados; Mukul Sharma; Keith Muir; Roland Veltkamp; Sebastian F Ameriso; Matthias Endres; Helmi Lutsep; Steven R Messé; J David Spence; Krassen Nedeltechev; Kanjana Perera; Gustavo Santo; Veronica Olavarria; Arne Lindgren; Shrikant Bangdiwala; Ashkan Shoamanesh; Scott D Berkowitz; Hardi Mundl; Stuart J Connolly; Robert G Hart
Journal:  Lancet Neurol       Date:  2018-09-28       Impact factor: 44.182

10.  Usefulness of Clinical Prediction Rules, D-dimer, and Arterial Blood Gas Analysis to Predict Pulmonary Embolism in Cancer Patients.

Authors:  Asifa Karamat; Shazia Awan; Muhammad Ghazanfar Hussain; Fahad Al Hameed; Faheem Butt; Ali Saeed Wahla
Journal:  Oman Med J       Date:  2017-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.